Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-naïve Vogt-Koyanagi-Harada disease patients

BACKGROUND: High dose systemic glucocorticoid is the main therapy of treatment-naïve Vogt-Koyanagi-Harada (VKH) disease. However, series side effects induced by high dose systemic glucocorticoid frequently occur, which makes alternative therapy necessary for certain patients. This study sought to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shizhao, Tao, Tianyu, Li, Zhaohuai, Chen, Binyao, Huang, Zhaohao, Liu, Xiuxing, Li, He, Xie, Lihui, Feng, Wen, Su, Wenru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279783/
https://www.ncbi.nlm.nih.gov/pubmed/35845536
http://dx.doi.org/10.21037/atm-22-2668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279783/
https://www.ncbi.nlm.nih.gov/pubmed/35845536
http://dx.doi.org/10.21037/atm-22-2668

Ejemplares similares